secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcadia Biosciences, Inc. (RKDA)
CIK:        0001469443
Form:       8-K
Filed at:   2024-11-12T23:59:59+00:00
Accession:  0000950170-24-125393
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcadia Biosciences Q3 revenue up 18% to $1.5M; net loss narrows to $1.6M
-------------------------------------------------------------------------

- Total revenues $1.537M, +18% YoY; Zola coconut water revenue +55% YoY.
- Zola retail distribution expanded 68% vs Q3 2023.
- Net loss attributable to common stockholders $1.612M ($1.18/share) vs $2.567M ($1.89) in Q3 2023.
- Operating expenses increased 22% to $3.297M due to higher revenues and severance costs.
- Cash and cash equivalents $3.936M, down from $6.518M at Dec 31, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1469443/000095017024125393/0000950170-24-125393-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1469443/000095017024125393/rkda-20241112.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-125393

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer